Paper ยท 37561981
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.
Pappas L and 30 others. JCO Precis Oncol, 2023. Cited by 20 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. Papers, record 37561981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37561981
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangiocarcinoma | Major topic |
| Bile Duct Neoplasms | Major topic |
| Humans | |
| Young Adult | |
| Adolescent | |
| Middle Aged | |
| Retrospective Studies | |
| Bile Ducts, Intrahepatic | |
| Biology |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 CA248473 | NCI NIH HHS | United States | K08CA248473 | PubMed and NIH | NIH RePORTER |
| P50 CA127003 | NCI NIH HHS | United States | P50CA127003 | PubMed and NIH | NIH RePORTER |
| R37 CA225655 | NCI NIH HHS | United States | R37CA225655 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,317,994 | Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. | J Am Coll Surg | 2009 | https://conductscience.org/library/papers/19317994 | PubMed |
| 2 | 28,376,186 | Colorectal Cancer Incidence Patterns in the United States, 1974-2013. | J Natl Cancer Inst | 2017 | https://conductscience.org/library/papers/28376186 | PubMed |
| 3 | 24,445,538 | Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. | Nat Commun | 2014 | https://conductscience.org/library/papers/24445538 | PubMed |
| 4 | 27,655,244 | Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database. | BMC Gastroenterol | 2016 | https://conductscience.org/library/papers/27655244 | PubMed |
| 5 | 28,122,072 | Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer. | JAMA Surg | 2017 | https://conductscience.org/library/papers/28122072 | PubMed |
| 6 | 28,024,947 | Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement. | J Mol Diagn | 2017 | https://conductscience.org/library/papers/28024947 | PubMed |
| 7 | 33,692,336 | Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33692336 | PubMed |
| 8 | 30,156,052 | Breast cancer in adolescents and young adults. | Pediatr Blood Cancer | 2018 | https://conductscience.org/library/papers/30156052 | PubMed |
| 9 | 21,120,307 | Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients. | Clinics (Sao Paulo) | 2010 | https://conductscience.org/library/papers/21120307 | PubMed |
| 10 | 30,854,646 | Clinical and molecular characterization of early-onset colorectal cancer. | Cancer | 2019 | https://conductscience.org/library/papers/30854646 | PubMed |
1 to 10 of 43
See all 43 referencesCited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,948,669 | Early-onset biliary tract cancers: clinical and molecular insights. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42948669 | PubMed |
| 42,787,855 | Care delivery among patients with early-onset versus average-onset cholangiocarcinoma: a nationwide retrospective analysis. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42787855 | PubMed |
| 42,444,838 | Survival outcomes and prognostic factors in de novo advanced biliary tract cancer: insights from a Saudi multicenter cohort. | Front Oncol | 2026 | https://conductscience.org/library/papers/42444838 | PubMed |
| 42,442,510 | Molecular Subtypes of Cholangiocarcinoma and Their Translational Implications. | Gastroenterology | 2026 | https://conductscience.org/library/papers/42442510 | PubMed |
| 42,426,481 | Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic Cholangiocarcinoma. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42426481 | PubMed |
| 42,223,137 | Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial. | J Clin Oncol | 2026 | https://conductscience.org/library/papers/42223137 | PubMed |
| 42,145,505 | Impact of small area-level deprivation on survival outcomes in patients with Cholangiocarcinoma: a population-based multilevel survival analysis. | Front Public Health | 2026 | https://conductscience.org/library/papers/42145505 | PubMed |
| 42,086,664 | Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42086664 | PubMed |
| 41,994,026 | Clinical and molecular characteristics of early-onset pancreatic and biliary cancers. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/41994026 | PubMed |
| 41,850,249 | Early-Onset Digestive System Cancers: Risk Factors and Clinicopathological and Molecular Features Across Organ Sites. | Cancer Sci | 2026 | https://conductscience.org/library/papers/41850249 | PubMed |
1 to 10 of 18
See all 18 cited byGenes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| APRT | 353 | PubTator's text mining | https://conductscience.org/library/genes/353 | NCBI Gene |
| ARID1A | 8,289 | PubTator's text mining | https://conductscience.org/library/genes/8289 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CD274 | 29,126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| ERBB2 | 2,064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| FGFR2 | 2,263 | PubTator's text mining | https://conductscience.org/library/genes/2263 | NCBI Gene |
| IDH1 | 3,417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
1 to 10 of 17
See all 17 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37561981
GET https://conductscience.org/api/papers/v1/37561981/authors?page=2